Search results for "APR"

showing 10 items of 2648 documents

A combined therapy for limb apraxia and related anosognosia.

2019

Left hemisphere stroke frequently leads to limb apraxia, a disorder that has been reported to impact independence in daily life and rehabilitation success. Nonetheless, there is a shortcoming in research and availability of applicable trainings. Further, to date, anosognosia for limb apraxia has largely been neglected. Therefore, we developed a Naturalistic Action Therapy that trains object selection and application with an errorless learning approach and which includes supported self-evaluation. The current study presents the results of two stroke patients participating in the training. The procedure entailed two baseline and one post-training sessions including standardized limb apraxia a…

Male030506 rehabilitationmedicine.medical_specialtygenetic structuresApraxiasmedia_common.quotation_subjectmedicine.medical_treatmenteducationbehavioral disciplines and activitiesLateralization of brain functionUpper Extremity03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationddc:150Arts and Humanities (miscellaneous)Occupational TherapymedicineHumansStrokeApplied Psychologymedia_commonAgedAged 80 and overRehabilitationbusiness.industryAnosognosiaRehabilitationStroke RehabilitationLimb apraxiaMiddle Agedmedicine.diseaseNaturalistic Action Therapy limb apraxia Anosognosia for apraxia rehabilitation tool-useIndependencebody regionsStrokeNeuropsychology and Physiological PsychologyAgnosiaCombined therapyFemale0305 other medical sciencebusiness030217 neurology & neurosurgeryPsychomotor PerformanceNeuropsychological rehabilitation
researchProduct

Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

2015

Introduction This work was undertaken to delineate intracellular signaling pathways for the PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate and adenosine A2A receptors (A2AR). Methods After apremilast and LPS incubation, intracellular cAMP, TNF-α, IL-10, IL-6 and IL-1α were measured in the Raw264.7 monocytic murine cell line. PKA, Epac1/2 (signaling intermediates for cAMP) and A2AR knockdowns were performed by shRNA transfection and interactions with A2AR and A2BR, as well as with methotrexate were tested in vitro and in the murine air pouch model. Statistical differences were determined using one or two-way ANOVA or Student’s t test. The alpha nominal…

MaleAdenosineReceptor Adenosine A2AImmunologyBlotting WesternAdenosine A2A receptorGene ExpressionPharmacologyBiologyCell LineMiceRheumatologyPhenethylaminesmedicineCyclic AMPImmunology and AllergyAnimalsGuanine Nucleotide Exchange FactorsReceptorIC50ArtritisReverse Transcriptase Polymerase Chain ReactionTumor Necrosis Factor-alphaMacrophagesAdenosineMolecular biologyCyclic AMP-Dependent Protein KinasesThalidomideMethotrexateMechanism of actionAntirheumatic AgentsCytokinesTumor necrosis factor alphaRNA InterferenceApremilastPhosphodiesterase 4 Inhibitorsmedicine.symptomInflammation MediatorsIntracellularMedicamentsmedicine.drugResearch Article
researchProduct

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational…

2021

Abstract Background and Aims The MARS post-marketing, observational study evaluates glecaprevir/pibrentasvir in a large population of Italian patients who are infected with HCV. Patients and Methods Achievement of SVR12 was the primary endpoint in the overall population and by subpopulations of interest (treatment-naive and treatment-experienced patients, subjects infected with different HCV genotype/sub-genotype, cirrhotic and non-cirrhotic patients, patients with different severity of fibrosis, patients with an APRI score ≥1, subjects with comorbidities, HIV-coinfected patients, elderly patients and people who use drugs). Safety and quality of life (assessed by SF-36 and Work Productivity…

MaleAdultmedicine.medical_specialtyPyrrolidinesQuinoxalineSustained Virologic ResponseSettore MED/12 - GASTROENTEROLOGIAPopulationAntiviral AgentselderlyBenzimidazoleGLE/PIBQuinoxalinesInternal medicineDrug CombinationClinical endpointmedicineProduct Surveillance PostmarketingHumansProspective StudieseducationAdverse effectAgedAntiviral AgentSulfonamideseducation.field_of_studyHepatologybusiness.industrySettore MED/09 - MEDICINA INTERNAGastroenterologyPWUDGlecaprevirMiddle Agedelderly; GLE/PIB; HCV; PWUDHepatitis C ChronicPibrentasvirDiscontinuationDrug CombinationsGLE/PIB; HCV; PWUD; elderlyItalyCohortHCVQuality of LifeBenzimidazolesFemaleObservational studybusiness
researchProduct

Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors

1995

The effects of the 5-HT4 receptor agonists BIMU 8, BIMU 1, renzapride and of the 5-HT1p receptor agonist 5-hydroxyindalpine on basal and electrically evoked outflow of tritium were studied in guinea-pig longitudinal muscle myenteric plexus preparations preincubated with [3H]choline. Muscle contractions were recorded simultaneously. BIMU 8 caused a calcium dependent and tetrodotoxin sensitive increase in basal [3H]outflow that was assumed to represent release of [3H]acetylcholine. In addition, BIMU 8 enhanced the release of [3H]acetylcholine and twitch contractions evoked by submaximal electrical stimulation. Ondansetron (1 μmol/l) did not change the effects of BIMU 8, but DAU 6285 and tropi…

MaleAgonistIBMXPhosphodiesterase Inhibitorsmedicine.drug_classGuinea PigsMyenteric PlexusStimulationIn Vitro TechniquesPharmacologyCholineBridged Bicyclo Compoundschemistry.chemical_compoundPiperidinesmedicineAnimalsMyenteric plexusPharmacologyGeneral MedicineBridged Bicyclo Compounds HeterocyclicAcetylcholineElectric StimulationSerotonin Receptor AgonistsRenzaprideNicotinic agonistchemistryReceptors SerotoninAnesthesiaBenzamidesCholinergicBenzimidazolesFemaleSerotonin AntagonistsAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

2014

It is known that the gastrointestinal tract (GIT) microbiota responds to different antibiotics in different ways and that while some antibiotics do not induce disturbances of the community, others drastically influence the richness, diversity, and prevalence of bacterial taxa. However, the metabolic consequences thereof, independent of the degree of the community shifts, are not clearly understood. In a recent article, we used an integrative OMICS approach to provide new insights into the metabolic shifts caused by antibiotic disturbance. The study presented here further suggests that specific bacterial lineage blooms occurring at defined stages of antibiotic intervention are mostly associa…

MaleAnabolismAntibioticsGene ExpressionGut floraGastrointestinal FunctionBioinformaticsprokaryotesFecesRNA Ribosomal 16SSystems and Synthetic Biologyhuman fecal microbiota1506MetaproteomicGut Microbiotadatabase2. Zero hungerlong-term impactsGastrointestinal tract0303 health sciencesSysteem en Synthetische Biologiehuman intestinal microbiotabiologyMicrobiotaGastroenterologyBiodiversity3. Good healthAnti-Bacterial AgentsBacterial Typing TechniquesArticle AddendumRNA BacterialInfectious DiseasesMetabolomecommunitymetaproteomicsHuman gut microbiotaMicrobiology (medical)DNA BacterialDisturbance (geology)medicine.drug_classperturbationMetabolomicbeta-LactamsMicrobiologyMicrobiologyresistance03 medical and health sciencesMetagenomicAntibiotic therapyMetabolomemedicineHumans030304 developmental biologyAgedVLAGBacteria030306 microbiologyGene Expression ProfilingColonic MicrofloraAkkermansiaAntibiotic therapybiology.organism_classificationGastrointestinal TractEnterococcusGene Expression RegulationMetaproteomicsMetatranscriptomicGastrointestinal functionmetabolismMeta-Analysis
researchProduct

Development of an antibody-based capture enzyme-linked immunosorbent assay for detecting echinostoma caproni (trematoda) in experimentally infected r…

2003

The present study reports on the development of a coproantigen capture enzyme-linked immunosorbent assay (ELISA) for detecting Echinostoma caproni in experimentally infected rats. The capture ELISA was based on polyclonal rabbit antibodies that recognize excretory–secretory (ES) antigens. The detection limit of pure ES was 3 ng/ml in sample buffer and 60 ng/ml in fecal samples. The test was evaluated using a follow-up of 10 rats experimentally infected with 100 metacercariae of E. caproni, and the results were compared with those of other diagnostic methods such as parasitological examination and antibody titers determined by indirect ELISA. Coproantigens were detected in all the infected r…

MaleAntibodies HelminthEchinostoma caproniEnzyme-Linked Immunosorbent Assay:CIENCIAS DE LA VIDA [UNESCO]ExcretionFecesAntigenEchinostomaCoproantigen ExcretionUNESCO::CIENCIAS DE LA VIDAAnimalsRats WistarAntibodyEcology Evolution Behavior and SystematicsFecesEchinostomiasisbiology:CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animal [UNESCO]Antibody titerInfected ratsbiology.organism_classificationAntibody ; Echinostoma caproni ; Infected rats ; Coproantigen Excretion ; InmunosorbentVirologyRatsKineticsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animalPolyclonal antibodiesAntigens HelminthImmunologybiology.proteinParasitologyRabbitsAntibodyTrematodaEchinostomaInmunosorbent
researchProduct

Kinetics of antibodies and antigens in serum of mice experimentally infected with echinostoma caproni (trematoda: echinostomatidae)

2005

The present study reports on the kinetics of antibodies and antigens in serum of mice experimentally infected with 75 metacercariae of Echinostoma caproni during the first 12 wk postinfection (wpi). Antibody titers in the serum of mice were determined by an indirect enzyme-linked immunosorbent assay (ELISA) using excretory/secretory (ES) antigens of E. caproni. The early detection of antibodies against ES antigens of E. caproni is feasible using indirect ELISA. Mice developed significant antibody responses at 2 wpi, and the values progressively increased until the end of the experiment. This may be related to the intestinal absorption of adult worm antigens that induces humoral responses. T…

MaleAntibodies HelminthEnzyme-Linked Immunosorbent AssayEchinostoma caproniImmunoglobulin GIntestinal absorptionAntibodies:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyMiceAntigenEchinostomaUNESCO::CIENCIAS DE LA VIDAAnimalsAntigensEcology Evolution Behavior and SystematicsEchinostomiasisMice Inbred ICRbiologyBiomphalariaAntibody titer:CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animal [UNESCO]biology.organism_classificationUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animalDisease Models AnimalKineticsPolyclonal antibodiesAntibodies ; Antigens ; Echinostoma caproniAntigens HelminthImmunoglobulin GImmunologybiology.proteinParasitologyTrematodaEchinostomaAntibody
researchProduct

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype…

2017

Over the last 5 years, therapies for hepatitis C virus (HCV) infection have improved significantly, achieving sustained virologic response (SVR) rates of up to 100% in clinical trials in patients with HCV genotype 1. We investigated the effectiveness and safety of ombitasvir/paritaprevir/ritonavir +/- dasabuvir in an early access programme. This was a retrospective, multicentre, national study that included 291 treatment-naive and treatment-experienced patients with genotype 1 or 4 HCV infection. Most patients (65.3%) were male, and the mean age was 57.5years. The mean baseline viral load was 6.1 log, 69.8% had HCV 1b genotype, 72.9% had cirrhosis and 34.7% were treatment-naive. SVR at 12 w…

MaleCirrhosisSustained Virologic ResponseHepacivirusmedicine.disease_causechemistry.chemical_compound0302 clinical medicinesevere fibrosisdasabuvirMedicineAged 80 and overMiddle AgedInfectious DiseasesTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologyDrug Therapy CombinationFemaleViral loadmedicine.drugAdultmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsGenotypeHepatitis C viruscompassionate useAntiviral Agents03 medical and health sciencesVirologyInternal medicineHumansAdverse effectAgedRetrospective StudiesHepatologybusiness.industryRibavirinparitaprevirHepatitis C Chronicmedicine.diseaseVirologydigestive system diseasesOmbitasvirDiscontinuationombitasvirchemistryParitaprevirSpainhepatitis Cbusiness
researchProduct

Differential metabolic profiling of non-pure trisomy 21 human preimplantation embryos.

2012

Objective To investigate the metabolomic signature of trisomy 21 preimplantation human embryos by a noninvasive approach using mass spectrometry– (MS-) and nuclear magnetic resonance spectroscopy– (NMR-) based metabolic profiling platforms. Design A total of 171 spent media samples were collected from day 3 embryos and comparatively analyzed by MS analysis (chromosomally normal embryos, n=15; trisomy 21 embryos, n=15) and a matched control media group (without embryo, n=14) and by NMR spectroscopy (normal embryos, n=39; trisomy 21 embryos, n=35; monosomy 21 embryos, n=24) and a matched control media group (without embryo, n=29). Setting IVF clinic/preimplantation genetic diagnosis (PGD) uni…

MaleDown syndromeSex Determination Analysisanimal structuresMagnetic Resonance SpectroscopyAneuploidyFertilization in VitroBiologyPreimplantation genetic diagnosisAndrosteroneGas Chromatography-Mass SpectrometryAndrologyEmbryo Culture Techniqueschemistry.chemical_compoundPredictive Value of TestsPregnancymedicineHumansMetabolomicsBlastocystCaproatesIn Situ Hybridization FluorescencePreimplantation DiagnosisGeneticsAndrosteroneObstetrics and GynecologyEmbryomedicine.diseaseAneuploidyCulture Mediamedicine.anatomical_structureBlastocystReproductive MedicinechemistryCase-Control Studiesembryonic structuresFeasibility StudiesFemaleDown SyndromeTrisomyChromosome 21BiomarkersChromatography LiquidFertility and sterility
researchProduct

Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins

2020

Objective Cancer cachexia and muscle loss are associated with increased morbidity and mortality. In preclinical animal models, blocking activin receptor (ACVR) ligands has improved survival and prevented muscle wasting in cancer cachexia without an effect on tumour growth. However, the underlying mechanisms are poorly understood. This study aimed to identify cancer cachexia and soluble ACVR (sACVR) administration-evoked changes in muscle proteome. Methods Healthy and C26 tumour-bearing (TB) mice were treated with recombinant sACVR. The sACVR or PBS control were administered either prior to the tumour formation or by continued administration before and after tumour formation. Muscles were an…

MaleEXPRESSIONActivin receptor; APR; C26; Cancer cachexia; Nrk2; OXPHOSlcsh:Internal medicineCachexiaREVERSALActivin ReceptorsMETABOLISMactivin receptorOxidative PhosphorylationCell Line TumorAnimalsMuscle Skeletallcsh:RC31-1245aineenvaihduntaSerpinslihassolut318 Medical biotechnologyNrk2Cancer cachexiaMyostatinNADOXPHOSMUSCULAR-DYSTROPHYActivinsMitochondriaActivin receptorDisease Models AnimalMuscular AtrophyMICESIRTUINSOriginal ArticlesyöpätauditproteiinitC26lihassurkastumasairaudetAPRAcute-Phase Proteinscancer cachexia
researchProduct